Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Gut Microbiota in Nonalcoholic Fatty Liver Diseases With and Without Type-2 Diabetes Mellitus Publisher Pubmed



Ebrahimzadeh Leylabadlo H1, 2, 3 ; Samadi Kafil H1, 4 ; Farajnia S5 ; Shanehbandi D6 ; Yaghoub Moaddab S1 ; Feizabadi MM7 ; Ghotaslou R1, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, 51666 14766, Iran
  2. 2. Student Research Committee, Faculty of Medicine, Tabriz, Iran
  3. 3. Department of Bacteriology and Virology, Faculty of Medicine, Tabriz, Iran
  4. 4. Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  5. 5. Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  6. 6. Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  7. 7. Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Source: European Journal of Gastroenterology and Hepatology Published:2021


Abstract

Background and aims The association between nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) is not very well described but gut microbiota composition is mentioned as a risk factor. The present study aimed to characterize the differences of dominant gut microbiota phyla among people with NAFLD as compared to T2DM and control groups. Patients and methods The major bacterial phylum of gut microbiota including Bacteroidetes, Firmicutes, Actinobacteria, Proteobacteria, and total bacteria of 15 NAFLD patients with T2DM, 15 NAFLD patients without T2DM, 15 patients with T2DM, and 20 healthy control subjects were assessed by a quantitative PCR (qPCR). Results NAFLD patients with T2DM had significantly higher BMI, triglyceride level, and total cholesterol level were compared with controls (Pv < 0.05). Bacteroidetes and Firmicutes phyla were significantly low in NAFLD patients with T2DM (Firmicutes, 2.55 ± 2.25, Pv 0/0002 and Bacteroidetes, 1.55 ± 2.29, Pv 0/0007), while the content of Proteobacteria and Actinobacteria was high in NAFLD patients with T2DM group and there were no significant differences between phyla with NAFLD patients with T2DM group (Pv > 0.05). Furthermore, Firmicutes copy number was lower in the separate groups of NAFLD and T2DM as compared to the healthy controls (Pv < 0.05). Conclusions This study performed gut microbiota for the first time among NAFLD and TDM patients separately and together. This investigation indicated that NAFLD patients with T2DM have a different gut composition in comparison to NAFLD, T2DM alone, which could be associated with disease development. © 2021 Lippincott Williams and Wilkins. All rights reserved.
Other Related Docs
12. The Landscape of Microbiota Research in Iran; a Bibliometric and Network Analysis, Journal of Diabetes and Metabolic Disorders (2020)
17. Gut Microbiota: A Perspective of Precision Medicine in Endocrine Disorders, Journal of Diabetes and Metabolic Disorders (2020)
19. Gut Microbiota-Derived Metabolites in Obesity: A Systematic Review, Bioscience of Microbiota# Food and Health (2020)
20. Inspection of Heritable Gut Microbiota Roles in Obesity, Journal of Biological Regulators and Homeostatic Agents (2023)